IVABRADINE and CARDIAC FAILURE

Overview

CARDIAC FAILURE is the #5 most commonly reported adverse reaction for IVABRADINE, manufactured by Amgen Inc. There are 324 FDA adverse event reports linking IVABRADINE to CARDIAC FAILURE. This represents approximately 2.7% of all 12,129 adverse event reports for this drug.

Patients taking IVABRADINE who experience cardiac failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE is a less commonly reported adverse event for IVABRADINE, but still significant enough to appear in the safety profile.

Other Side Effects of IVABRADINE

In addition to cardiac failure, the following adverse reactions have been reported for IVABRADINE:

• OFF LABEL USE — 1,295 reports
• DYSPNOEA — 460 reports
• HYPOTENSION — 413 reports
• DIZZINESS — 350 reports
• FATIGUE — 317 reports
• DRUG INTERACTION — 308 reports
• DRUG INEFFECTIVE — 270 reports
• NAUSEA — 253 reports
• BRADYCARDIA — 248 reports
• HEADACHE — 231 reports

Other Drugs Associated with CARDIAC FAILURE

The following drugs have also been linked to cardiac failure in FDA adverse event reports:

Does IVABRADINE cause CARDIAC FAILURE?

CARDIAC FAILURE has been reported as an adverse event in 324 FDA reports for IVABRADINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE with IVABRADINE?

CARDIAC FAILURE accounts for approximately 2.7% of all adverse event reports for IVABRADINE, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE while taking IVABRADINE?

If you experience cardiac failure while taking IVABRADINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages